VHL and kidney cancer: Additionally, we treated MS147 to 786‐O cells, a kidney cancer cell line that contains a truncated, inactive VHL (and thus cannot be utilized by VHL‐recruiting PROTACs),[45] to further demonstrate the correlation between MS147's BMI1/RING1B degradation activity and its antiproliferative effect.